Biodesix, Inc. (BDSX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Biodesix, Inc. (BDSX) is up 155.2% since the beginning of the year. At $17 per share, BDSX is trading 14.2% below its 52-week high of $20. Investors who bought $1,000 worth of BDSX shares 5 years ago would now be looking at an investment worth $60.

Biodesix, Inc. (BDSX) has returned 155.15% so far this year and 231.11% over the past 12 months.

Based on dividend-adjusted daily data since Oct 28, 2020, BDSX's average daily return is +0.01%, while the average monthly return is -1.36%.

Historically, 38% of months were positive and 62% were negative. The best month was Nov 2022 with a return of +98.0%, while the worst month was May 2025 at -43.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 14 months.

On a daily basis, BDSX closed higher 44% of trading days. The best single day was Jan 12, 2026 with a return of +48.0%, while the worst single day was May 14, 2025 at -38.7%.

Biodesix, Inc. has an annualized alpha of -12.28%, beta of 0.93, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 28, 2020.

• This stock participated in 157.26% of S&P 500 Index downside but only -40.96% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BDSX ranks 88 for risk / return — in the top 88% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Biodesix, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biodesix, Inc. was 99.30%, occurring on May 14, 2025. The portfolio has not yet recovered.

The current Biodesix, Inc. drawdown is 97.22%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Biodesix, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Biodesix, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.